Levetiracetam Noridem (Levetiracetam)

• Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in various seizure types.
• Partial seizures: helps achieve seizure control and reduce frequency of focal episodes.
• Generalized tonic‑clonic seizures: contributes to preventing convulsive episodes across the brain.
• Myoclonic seizures: assists in decreasing sudden muscle jerks associated with epilepsy.

• Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This action reduces excessive neuronal excitability, thereby decreasing the likelihood of seizure propagation throughout the central nervous system.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dizziness: transient sensation of light‑headedness.
• Fatigue: feeling unusually tired or weak.
• Headache: mild to moderate cranial pain.
• Somnolence: increased sleepiness during the day.
• Irritability: mood changes or agitation.
• Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects

• Severe allergic reactions: rash, swelling, or difficulty breathing.
• Stevens‑Johnson syndrome: rare but serious skin disorder.
• Blood dyscrasias: abnormal blood cell counts.
• Suicidal thoughts: emergence of depressive or suicidal ideation.
• Severe skin rash: widespread erythema or blistering.
• Respiratory depression: markedly reduced breathing effort.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential risks.

• Renal impairment: adjust dose based on creatinine clearance.
• Pregnancy category B: weigh benefits against potential risks.
• Mood changes: monitor for depression or agitation.
• Discontinuation: avoid abrupt cessation to prevent seizure worsening.
• Hepatic impairment: use with caution in liver disease.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam may interact with other medications, requiring careful assessment.

Major Interactions (Avoid)

• Carbamazepine: reduces levetiracetam plasma levels.
• Phenytoin: may lower levetiracetam effectiveness.
• Phenobarbital: induces metabolism, decreasing drug exposure.
• Rifampin: strong enzyme inducer that diminishes levetiracetam concentrations.

Moderate Interactions (Monitor Closely)

• Valproic acid: can increase levetiracetam levels.
• Alcohol: may enhance central nervous system depression.
• Other CNS depressants: monitor for additive sedation.
• Oral contraceptives: levetiracetam may reduce hormonal efficacy.